Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Am J Hematol. 2021 Aug 19;96(11):1420–1428. doi: 10.1002/ajh.26314

Fig. 2. Overall survival from the time of TP53 mutation.

Fig. 2.

Fig. 2.

A.) Overall survival for the whole population, B.) Overall survival stratified by TP53 variant allelic frequency <20% and ≥ 20%, C.) Overall survival stratified by p53 protein expression by immunohistochemistry